This year’s CPHI conference in Europe will introduce a new sustainability summit, as well as exhibitor zones focusing on AI, contamination control and logistics. CPHI...

Novo Nordiskhas announced headline results from the cardiovascular outcomes from a phase 3 trial. While ziltivekimab demonstrated target engagement and inhibition of the IL-6 pathway,...

Kodiak Sciences Inc. has completed enrolment of the first 300-patient cohort in its clinical trial, supporting pivotal analysis of the KSI-101 phase 3 programme...

ILC Dover, an Ingersoll Rand business and world leader in the innovative design and production for biopharmaceutical, pharmaceutical, and medical device markets, has announced...

Aureka Biotechnologies has closed financing of US$100 million. The company will direct proceeds primarily toward research and large-scale training of its next generation of biological...

Oncoinvent, a biotech company developing a receptor-independent alpha radiopharmaceutical to eradicate cancer cells in the abdominal cavity after surgery with a single, targeted dose,...

As a cyclospora outbreak continues to spread throughout the United States, Roche, in collaboration with subsidiary TIB MOLBIOL, has made available two new flexible and...

The US Food and Drug Administration (FDA) has approved Takeda’s Orzeyful (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy...

The European Commission (EC) has approved an extension of the indication for Sanofi’s MenQuadfi (meningococcal Group A, C, W and Y conjugate vaccine) to...

Schrödinger, Inc. has entered a strategic agreement with Bristol Myers Squibb (BMS) to deploy Bunsen, Schrödinger's agentic AI co-scientist, within its research organisation. Building on a...